Jim Simons Erasca, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Erasca, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,631,600 shares of ERAS stock, worth $3.26 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,631,600
Previous 2,008,500
18.77%
Holding current value
$3.26 Million
Previous $4.28 Million
21.44%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ERAS
# of Institutions
117Shares Held
74.3MCall Options Held
7.1KPut Options Held
40.1K-
Arch Venture Management, LLC Chicago, IL11.1MShares$22.1 Million33.14% of portfolio
-
Black Rock Inc. New York, NY6.98MShares$14 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.17MShares$12.3 Million0.17% of portfolio
-
Artal Group S.A. Luxembourg, N44.72MShares$9.44 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.34MShares$8.68 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $244M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...